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Abstract Six peptide toxins (Magi 1^6) were isolated from the
Hexathelidae spider Macrothele gigas. The amino acid sequen-
ces of Magi 1, 2, 5 and 6 have low similarities to the amino acid
sequences of known spider toxins. The primary structure of
Magi 3 is similar to the structure of the palmitoylated peptide
named PlTx-II from the North American spider Plectreurys
tristis (Plectreuridae). Moreover, the amino acid sequence of
Magi 4, which was revealed by cloning of its cDNA, displays
similarities to the Na+ channel modi¢er N-atracotoxin from the
Australian spider Atrax robustus (Hexathelidae). Competitive
binding assays using several 125I-labelled peptide toxins clearly
demonstrated the speci¢c binding a⁄nity of Magi 1^5 to site 3
of the insect sodium channel and also that of Magi 5 to site 4 of
the rat sodium channel. Only Magi 6 did not compete with the
scorpion toxin LqhKIT in binding to site 3 despite high toxicity
on lepidoptera larvae of 3.1 nmol/g. The Kis of other toxins
were between 50 pM for Magi 4 and 1747 nM for Magi 1.
In addition, only Magi 5 binds to both site 3 in insects
(Ki = 267 nM) and site 4 in rat brain synaptosomes (Ki = 1.2
nM), whereas it showed no a⁄nities for either mammal binding
site 3 or insect binding site 4. Magi 5 is the ¢rst spider toxin
with binding a⁄nity to site 4 of a mammalian sodium channel.
8 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
Key words: Spider; Peptide; Toxin; Insecticide; Structure;
Pharmacology; Ion channel
1. Introduction
Natural drugs that modulate ion channels represent a key
class of pharmaceutical agents across many therapeutic areas
and there is considerable potential for development of drugs
e¡ective to ion channels [1]. To study the interaction of nat-
ural ligands with ion channels, high binding a⁄nity ligands
are the best chemical probes to enable biochemical assays
when using limited amounts of ion channel preparations.
Moreover, small molecular weight natural ligands are gener-
ally preferred for ease of chemical synthesis, which avoids
natural extractions. Spider venoms contain strong peptide li-
gands with a variable range of molecular masses (3^12 kDa),
including a large diversity of ion channel antagonists compa-
rable to the venoms of other animals [2]. Therefore, spider
ion channel toxins are good candidates for the study of ion
channels. Several spider toxins targeting di¡erent types of
mammalian calcium channels and subtypes of potassium ion
channels have been identi¢ed: g-AgaIVA (P-type), g-gram-
motoxin (N-type), SNX-482 (R-type), hanatoxin (Kv2.1), hep-
tarotoxins (Kv4.2) (for a recent review [3]). Spider peptide
toxins modifying sodium channels have also been character-
ized. N-Atracotoxins from the Australian spiders Atrax robus-
tus [4] and Hadronyche versuta [5] bind to site 3 of insect and
mammal sodium channels [6]. Moreover, palutoxins and
ProTxs were isolated from the venom of the amaurobiid spi-
der Paracoelotes luctuosus and of the theraphosid spider
Thrixopelma pruriens, respectively [7,8]. Palutoxins block in-
activation of insect sodium channels [7], and ProTxs are an-
tagonists of rNav 1.8 sodium channels [8]. Most of the small
molecular weight ion channel toxins from spider venoms have
been successfully synthesized, and applied for pharmacologi-
cal and structural studies of ligand^receptor interactions [8^
10]. Moreover, some synthetic spider toxins have been used
for studies of ligand^receptor recognition in calcium and po-
tassium ion channels using ion channel mutants [9,11,12].
Other studies on the molecular interaction of ligand and re-
ceptor have employed synthetic mutants of ion channel li-
gands [13^15]. Therefore, small molecular weight high a⁄nity
ion channel ligands from spider venoms could be good can-
didates for this purpose.
Searching for small molecular weight peptide ligands a¡ect-
ing sodium ion channels, we report the isolation, chemical and
biochemical characterization of ¢ve peptides that bind to site
3 and site 4 of the sodium channel, and one peptide with
unknown mode of action from the venom of the hexathelid
spider Macrothele gigas.
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2. Material and methods
2.1. Biological materials
M. gigas venom was obtained by electrical stimulation of ¢eld-col-
lected spiders from the Sonai area in Iriomote, Japan. The crude
venom was frozen and stored at 320‡C until use. Endoproteinase
Glu-C (EC 3.4.21.19) was from Sigma (USA).
2.2. Isolation, amino acid sequence and mass spectrometry analysis of
M. gigas toxins
The crude venom (70 Wl) was resuspended in 0.1% aqueous tri-
£uoroacetic acid (TFA) containing 10% acetonitrile (CH3CN), and
the insoluble material was removed by centrifugation at 14 000Ug
for 5 min. The supernatant was fractionated directly by established
high performance liquid chromatography (HPLC) methods [16]. The
amino acid sequences and the mass spectra of the six major peptide
toxins from the whole venom were analyzed according to previously
published procedures [7].
2.3. Biological activity
Biological activity in insects (Spodoptera litura, tobacco cutworm)
and mice (C57/Bl6) was evaluated according to previously described
assays [7]. Negative controls were done with saline solution, and pos-
itive controls were performed with a toxic scorpion peptide LqhIV
isolated in our laboratory [17].
2.4. Neuronal membrane preparations
All bu¡ers contained a cocktail of proteinase inhibitors composed
of phenylmethylsulfonyl £uoride (50 Wg/ml), pepstatin A (1 WM), io-
doacetamide (1 mM) and 1,10-phenanthroline (1 mM). Insect and rat
brain synaptosomes were prepared from whole heads of adult cock-
roaches of Periplaneta americana and albino Sprague^Dawley rats,
respectively, according to a previously described method [18]. No
loss of binding activity was observed after 6 months at 380‡C. Mem-
brane protein concentration was determined using a Bio-Rad protein
assay, using bovine serum albumin (BSA) as standard.
2.5. Iodination of N-TxVIA, LqhKIT, BjxtrIT, Lqh2 and CssIV
N-TxVIA was iodinated as described [19]. The toxins were radio-
iodinated by 0.7 units of lactoperoxidase, 1 nmol of toxin and 0.5 mCi
carrier-free Na125I (Amersham, UK). The mono-iodotoxins were pu-
ri¢ed using an analytical Vydac reverse phase (RP) HPLC C18 col-
umn with a gradient of bu¡ers A (H2O, 0.01% TFA) and B (acetoni-
trile, 0.01% TFA) and eluted just after the non-modi¢ed toxin. The
gradient was from 0 to 15% of bu¡er B in 5 min, then from 15% to
40% in 120 min. The concentration of the radiolabeled toxin was
determined according to the speci¢c activity of the 125I corresponding
to 2500^3000 dpm/fmol of mono-iodotoxin, depending on the age of
the radiotoxin and by estimation of its biological activity.
2.6. Binding assays
Standard binding medium composition was: choline-Cl, 130 mM;
CaCl2, 1.8 mM; KCl, 5 mM; MgSO4, 0.8 mM; HEPES, 50 mM;
glucose 10 mM; and 2 mg/ml BSA. Wash bu¡er composition was:
choline-Cl, 140 mM; CaCl2, 1.8 mM; KCl, 5.4 mM; MgSO4. 0.8
mM; HEPES, 50 mM; 5 mg/ml BSA, pH 7.5. Insect (3^8 Wg of
protein/ml) and rat (0.4^1.0 mg/ml) membrane preparations were sus-
pended in 0.2 ml binding bu¡er, containing iodinated toxins. After
incubation for 60 min, the reactions were terminated by dilution with
2 ml ice-cold wash bu¡er. Separation of the free from bound toxin
was achieved under vacuum by rapid ¢ltration through GF/C ¢lters
(Whatman, Maidstone, UK) preincubated in 0.3% polyethyleneimine
(Sigma, USA). The ¢lters were then rapidly washed twice with 2 ml of
bu¡er. Non-speci¢c toxin binding was determined in the presence of a
high concentration of the unlabeled toxin and consisted typically of
5^35% of total binding. Competition binding experiments were ana-
lyzed using the computer program KaleidaGraph (Synergy Software,
Reading, MA, USA) using a non-linear Hill equation (for IC50 deter-
mination). The Kis were calculated by the equation Ki = IC50/(1+
(L*/Kd)), where L* is the concentration of hot toxin and Kd is its
dissociation constant [20].
2.7. Ampli¢cation of total cDNA and characterization of the partial
Magi 4 cDNA ends
The total RNA was prepared (from two venom glands of a female
spider) using TRIzol reagent according to the manufacturer’s protocol
(Invitrogen, San Diego, CA, USA). The ¢rst strand cDNA was syn-
thesized using Powerscript Reverse Transcriptase, 3PSMART CDS
primer II, and SMART II A oligonucleotides according to the man-
ufacturer’s protocol (BD Bioscience, Palo Alto, CA, USA), and was
ampli¢ed by polymerase chain reaction (PCR) with 5PPCR primer II
A and Advantage 2 polymerase (BD Bioscience), consisting of 95‡C
for 1 min and 24 cycles of 95‡C for 5 s, 65‡C for 5 s, and 68‡C for
6 min on a thermal cycler (Model GeneAmp PCR system 9600; PE
Biosystems, Foster City, CA, USA). All PCR ampli¢cations described
below were performed using EX-Taq polymerase (Takara Shuzo,
Kyoto, Japan) or rTaq DNA polymerase (Toyobo, Osaka, Japan).
The ¢rst-round PCR was performed with the ampli¢ed total cDNA
as templates, the oligo-dT anchor primer (Roche Diagnostics, Basel,
Switzerland) and the degenerate primers 5P-TG(T/C)GGIIIIAA(A/
G)(A/C)GIGCITGGTG(T/C)AA-3P (I represents inosine) correspond-
ing to the sequence Cys1^Lys9. The ¢rst PCR products reampli¢ed
with the anchor primer (Roche Diagnostics) and the degenerate prim-
ers, 5P-GA(A/G)AA(A/G)AA(A/G)GA(T/C)TG(T/C)TG(T/C)TG(T/
C)GG, corresponding to Glu10^Gly17. Both ¢rst- and second-round
PCR consisted of 95‡C for 30 s and ¢ve cycles of 95‡C for 15 s, 45‡C
for 30 s, and 72‡C for 1 min followed by 30 cycles of 95‡C for 15 s,
56‡C for 30 s, and 72‡C for 1 min (10 min in the last cycle). The
second-round PCR products were subcloned into TOPO TA-cloning
vector (Invitrogen, San Diego, CA, USA), and the inserts were am-
pli¢ed by PCR with M13 universal primers.
2.8. Determination of the 5P-end sequence of Magi 4 cDNA and
DNA sequencing
The ampli¢ed cDNA was dA-tailed with dATP and terminal trans-
ferase (Roche Diagnostics), and was subjected to PCR with the oligo-
dT anchor primer and a gene-speci¢c primer (GTTACGTATTTT-
TAATACA, complementary to nucleotides 457^476), consisting of
95‡C for 30 s and 35 cycles of 95‡C for 15 s, 55‡C for 30 s, and
72‡C for 1 min. The PCR products were subcloned and the inserts
were ampli¢ed as described above. All nucleotide sequences were de-
termined with Big-Dye sequencing kit ver.1.1 and a model 373 DNA
sequencer (PE Biosystems), and then analyzed with GENETYX-MAC
software (Software Development, Tokyo, Japan).
3. Results
3.1. Puri¢cation and chemical analysis of M. gigas major
peptides
The crude venom of both female and male species of
M. gigas contains similar peptide composition. However,
two extra peptides were found in the crude venom of the
male spiders at m/z of 3177.9 and 3270.1 indicating some
minor di¡erences between male and female spiders (Fig.
1A). Since the quantity of venom extracted was higher for
the female spiders than for the male spiders, only female spi-
der venom was pooled and fractionated using RP-HPLC (Fig.
1B). Eighty fractions were manually collected and evaporated
under vacuum conditions. Because of the small supply of ven-
om, only the major peak fractions of the spider venom were
selected for chemical and biological analysis. The six larger
peptide fractions (49, 51, 54, 55, 63 and 69) were further frac-
tionated by cation exchange chromatography. All six fractions
yielded a major peak containing a single molecule as observed
by mass spectrometric analysis. To ensure purity, the six pep-
tides were ¢nally puri¢ed to homogeneity by RP-HPLC using
a C4 column. The molecular masses of the major single mol-
ecules were 4563.0, 4940.3, 5222.8, 5150.0, 3286.8 and 4036.4
Da, respectively. The purity of all six peptides was further
con¢rmed by capillary zone electrophoresis. The molecules
were named Magi 1^6 corresponding to the fractions 49, 51,
54, 55, 63 and 69, respectively according to their elution times
under RP-HPLC conditions. Magi 1 was the most hydrophilic
molecule of all six since it had the earliest elution time under
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RP-HPLC. A mass spectrometric analysis of the six peptides
before and after alkylation indicated that Magi 1, 2 and 5
contained three disul¢de bridges, Magi 4 and 6 contained
four disul¢de bridges, and Magi 3 contained ¢ve disul¢de
bridges. Direct Edman degradation of ¢ve out of six alkylated
peptides allowed unequivocal identi¢cation of their ¢rst 29^35
amino acid residues. The complete amino acid sequences of
Magi 1, 2, 3, 5 and 6 were obtained after their enzymatic
digestion with chymotrypsin and subsequent Edman degrada-
tion of their individual enzymatically digested fragments.
Magi 4, the peptide with the lowest concentration of the six
in the spider venom, yielded only 23 residues and its enzy-
matic cleavage with lysine-C produced an internal fragment of
seven additional amino acid residues. Magi 4 was further
characterized by isolation of its mRNA from dissected venom
glands.
3.2. cDNA characterization and complete amino acid sequence
of Magi 4
To verify the full-length sequence of Magi 4, we initially
tried to clone the Magi 4 cDNA by rapid ampli¢cation of
cDNA ends (RACE) experiments. However, this attempt
did not succeed, most likely because of too small amount of
total RNA from a limited number of samples. Thus, we am-
pli¢ed whole cDNA of the spider venom employing the
SMART PCR cDNA system (see Section 2), and then applied
the resultant cDNA to the ¢rst-round PCR using degenerate
primers corresponding to Cys1^Lys9 in the Magi 4 fragment
followed by the nested PCR with the degenerate primers en-
coding the sequence Glu10^Gly17. Electrophoresis of the
nested-round PCR mixture revealed the ampli¢cation of a
major PCR product ofV0.25 kb (data not shown). Sequenc-
ing of the subcloned inserts demonstrated that all clones com-
prised essentially identical nucleotide sequences apart from
minor di¡erences in the 3P-terminal sequence, due to various
lengths of the poly(A) tracts. The predicted amino acid se-
quence showed that the sequence YNCVYA, which accorded
with the internal peptide fragment Tyr18^Ala23 in the partial
amino acid sequence of Magi 4 obtained by Edman degrada-
tion, was located immediately after the sequence derived from
Fig. 1. A: Mass spectrum of the crude venom of male and female M. gigas. B: RP-HPLC chromatogram of the crude female venom of M.
gigas. The numbers 49, 51, 54, 55, 63 and 69 represent the HPLC fractions containing the six major peptide toxins named Magi 1, 2, 3, 4, 5
and 6, respectively in A (mass/charge ratio) and B (retention times under RP-HPLC conditions).
Fig. 2. A cDNA and deduced amino acid sequence of Magi 4 pep-
tide toxin. The complete amino acid sequence of Magi 4 is under-
lined.
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degenerate primers. This result suggested that the cDNA
clone encoded the precursor of Magi 4. In an attempt to
determine the complete cDNA sequence, we performed 5P-
RACE with the primers speci¢c for the clone. A 0.4 kb single
clone was obtained and sequenced after subcloning, revealing
that the PCR product encoded an amino acid sequence that
completely agrees with the sequence of the Magi 4 fragments
obtained by Edman degradation. In addition, PCR products
ampli¢ed using di¡erent polymerases contained the identical
nucleotide sequence, con¢rming that artifacts did not generate
these cDNAs. By combining the nucleotide sequence identi¢ed
by these experiments, we determined the entire Magi 4 cDNA
sequence composed of 529 nucleotides. As shown in Fig. 2,
the open reading frame started with an initiation codon at
nucleotide 89, which conforms to the Kozak rule [21], and
terminated with a TAA stop codon at nucleotide 406. A poly-
adenylation consensus (ATTAAA) was found at nucleotide
509.
The open reading frame region was shown to encode a 105
residue Magi 4 precursor polypeptide. The Magi 4 transcript
was predicted to be translated with Met1, given that the hy-
drophobic moiety typical for a signal peptide region follows
this Met residue. A sequence absolutely identical to
CGSKRAWCKEKKDCCCGYNCVYA, determined by ami-
no acid sequence analysis, was found at residues 63^85, fol-
lowed by the 20 residues WYNQQSSCERKWKYLFTGEC
terminated with a stop codon TAA (Fig. 2) and containing
the predicted amino acid sequence YLFTGEC obtained by
enzymatic cleavage and Edman degradation. The location of
typical precursor convertase (PC) cleavage motifs RR or
RXRR [22] at residues 59^62 supported the notion that the
Magi 4 precursor is subjected to post-translational endopro-
teolysis at this site and that the Cys63 in the precursor is
positioned at the N-terminus of the mature Magi 4. This
¢nding was compatible with the fact that the ¢rst residue in
native Magi 4 was shown to be a cysteine residue by amino
acid sequence analysis. Taken together, these results revealed
that the entire Magi 4 sequence was CGSKRAWCKEKKD-
CCCGYNCVYAWYNQQSSCERKWKYLFTGEC (Fig. 2).
Furthermore, the presence of eight cysteine residues in the
Table 1
Amino acid sequences and molecular masses of M. gigas peptides (A) and identity and alignment to known spider toxins (B)
Percentage identity is shown based on Magi 1, Magi 3 and Magi 4, respectively. The sequence alignment was obtained from http://
www.ch.embnet.org/software/ClustalW.html. Gaps (-) have been introduced to enhance similarities.
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deduced Magi 4 sequence suggested that this peptide should
have four intramolecular disul¢de bridges. The theoretical
molecular mass value of the folded form of Magi 4 (with
four disul¢de bonds) was calculated to be 5150.0 Da, which
was in good agreement with the observed value of the native
form of 5149.9 Da. These results further con¢rmed the full-
length sequence of Magi 4 as elucidated above.
3.3. Similarities of M. gigas peptides to other spider toxins
Magi 1, 2, 3, 4, 5 and 6 are composed of 38, 40, 46, 43, 29,
and 38 amino acid residues, respectively (Table 1A). The ami-
no acid sequences of Magi 3 and 4 share some similarities to
the sequences of the neuropeptide PlTx-II from the venom of
the American plectreurid spider Plectreurys tristis [23,24] and
the N-atracotoxins from the Australian hexathelid spiders
A. robustus [4] and H. versuta [5] (Table 1B). The amino
acid sequences of Magi 1 and 2 are homologous to each other,
whereas both of them displayed no signi¢cant sequence sim-
ilarity to any other peptides. The amino acid sequences Magi
5 and 6 share no similarities with amino acid sequences of
known spider toxins.
3.4. Biological activity and binding experiments to sodium
channels
The six pure peptide toxins were injected to S. litura lep-
idoptera larvae and to mice (C57/Bl6). Magi 1 did not cause
any e¡ect when injected to either mice (20 pmol/g) or insects
(32.8 nmol/g). In insects, Magi 3 and 5 (10.3 and 8.6 nmol/g,
respectively) produced paralysis to the lepidopteran larvae.
However, paralysis in£icted by Magi 3 and Magi 5 was only
temporary and the insects recovered after 2 h post injection.
Magi 2, 4 and 6 induced £accid paralysis to the larvae. The
e¡ects caused by those peptides were lethal with LD50s of
17.6, 1.2 and 3.1 nmol/g, respectively. In mice, Magi 2 and
3 did not cause toxicity at 20 pmol/g. The three more hydro-
phobic toxins, Magi 4, 5, and 6, were lethal to mice with
LD50s of 0.15, 0.73 and 0.74 pmol/g, respectively (Table 2).
The toxic symptoms produced by the intracranial injection of
each hydrophobic peptide di¡er from the symptoms caused by
the others. Injection of Magi 4 to mice produced instantane-
ous sweating, urination, salivation, agitation, convulsion and
¢nally death. A low injection dose of Magi 5 caused lacrima-
tion, closure of the eyes and sweating. At high injection dose
of Magi 5 the mice showed extensive lacrimation and death.
Injection of Magi 6 into mice caused awkwardness of move-
ment, and respiration was labored until death. The £accid
paralysis caused by M. gigas peptides to larvae has also
been observed after injection of scorpion depressant toxins
to blow £y larvae. The scorpion depressant toxins a¡ect so-
dium channel of insects [25,26]. Although the symptoms
caused by injection of the pure Magi 4, 5, or 6 toxins to
mice could not be directly linked to a particular ion channel
receptor, they seem to act on the central nervous system [27].
To examine the mode of action of these peptide toxins in the
nervous system, rat and cockroach brain synaptosomes were
prepared. Competitive binding assays were performed using
125I-labelled scorpion (CssIV, LqhKIT, Lqh2, BjxtrIT) and
cone snail (N-TxVIA) peptide toxins that bind to three di¡er-
ent extracellular receptor sites of the sodium ion channel (Ta-
ble 2). The 125I-labelled scorpion toxins LqhKIT [28] and
BjxtrIT [29] were used as probes for binding to site 3 and
site 4 of the insect sodium channel, respectively [13]. The
125I-labelled scorpion toxins Lqh2 [30] and CssIV [31] were
used as probes for binding to site 3 and site 4 of the rat brain
sodium channel, respectively [32,33]. Furthermore, the cone
snail toxin, N-conotoxin TxVIA, binds with high a⁄nity to
site 6 on sodium channels in rat central nervous system [19].
Magi 1, 2, 3, 4 and 5 were shown to inhibit the binding of the
125I-labelled scorpion toxin LqhKIT to site 3 of the sodium
channel of cockroach synaptosomes. Magi 4 showed the
strongest competition against LqhKIT for site 3 of insect so-
dium channel with a Ki of 0.05 nM. Magi 2 and Magi 5
elicited the second and third most potent binding a⁄nity to
this site with Kis of 21 and 267 nM, respectively (Table 2).
Magi 1 and 3 showed the weakest competition for the same
site of insect sodium channels with Kis of 1747 and 1718 nM,
respectively (Table 2, Fig. 3A). None of the six peptide toxins
compete either with the scorpion toxin BjxtrIT (speci¢c for
site 4) or with the cone snail toxin N-TxVIA (speci¢c for site 6)
in binding to cockroach synaptosomes (Table 2). In rat brain
synaptosomes, only Magi 5 competed against the scorpion
toxin CssIV in binding to site 4 with a Ki of 1.2 nM. Finally,
none of the six peptide toxins competed either with the scor-
pion toxin Lqh2 (speci¢c for site 3) or with the cone snail
Table 2





BjxtrIT Ki (nM)c CssIV Ki (nM)c LqhKIT Ki (nM)c Lqh2 Ki (nM)c TxVIA Ki (nM)c
(site 4, insects) (site 4, rat) (site 3, insects) (site 3, rat) (site 6, rat/insect)
Magi 1 s 32.8 [s 32.8] s 20 s 1000 s 1000 1747V 220 s 1000 s 1000
Magi 2 17.6 [17.6] s 20 s 1000 s 1000 21V 1.8 s 1000 s 1000
Magi 3 10.3 [s 32.8] s 20 s 1000 s 1000 1718V 193 s 1000 s 1000
Magi 4 1.2 [1.2] 0.15 s 1000 s 1000 0.05V 0.004 s 1000 s 1000
Magi 5 8.6 [s 32.8] 0.73 s 1000 1.2V 0.2 267V 31 s 1000 s 1000
Magi 6 3.1 [3.1] 0.74 s 1000 s 1000 s 2000 s 1000 s 1000
Cold toxind 0.45V 0.07 0.38V 0.08 0.19V 0.03 0.2V 0.06 2.5V 0.4e
aFor insects, the carrier solution was dH2O and were injected with a microsyringe. ED50 and LD50 values were based on 50% paralysis and
50% mortality of treated insects at 2 and 24 h post injection, respectively. ED50 and LD50 (in brackets) values were obtained by probit analysis
of data from six groups of 15 S. litura larvae.
bThe carrier solution was 5 Wl of BSA (20 mg/ml in 0.9% NaCl) and mice were injected with a 10 Wl microsyringe ¢tted with a glass capillary.
Intracranial injection in 5 week old male mice (C57/Bl6, approx. 20 g). LD50 values were based on 50% mortality of treated insects at 24 h
post injection and were obtained by probit analysis of data from six groups of ¢ve animals each.
cKi values were determined from competition binding curves of the indicated toxin on cockroach and rat neuronal membranes. The values rep-
resent the meanVS.E.M. of at least two independent experiments.
dCold toxin values represent the Ki of the competitive binding curves against the radiolabeled toxins by the native peptide.
eValue obtained from [19].
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toxin N-TxVIA (site 6) in binding to rat brain synaptosomes
(Table 2). Magi 6 could not compete with any radiolabeled
toxins in binding to cockroach or rat brain sodium channels,
and thus, the mode of action of Magi 6 remains unknown.
However, the rapid and strong lethality of Magi 6 towards
mice is suggestive of a strong antagonist action on the rat and
insect nervous systems. Taken together, these results led to the
conclusion that Magi 1^5 exhibit speci¢c inhibitory e¡ects on
site 3 of the insect sodium channel and that Magi 5 also serves
as the rat sodium channel blocker that speci¢cally binds to
site 4.
4. Discussion
In search of small molecular weight peptide ligands, with
new pharmacological speci¢cities, for the study of ionic chan-
nels, we investigated for the ¢rst time the peptide composition
of the venom of the spider M. gigas. The mode of action of
¢ve of the major peptides of the venom of M. gigas was found
to be towards the sodium channel.
The venom of M. gigas contains two toxic peptides (Magi 3
and 4) that have high amino acid sequence similarities to the
peptide toxins found in the plectreurid North American spider
P. tristis, and the toxic peptide toxins found in the hexathelid
Australian spiders A. robustus and H. versuta. Although the
hexathelids M. gigas and A. robustus as well as the plectreurid
P. tristis belong to di¡erent suborders, peptides similar to
Magi 3 and 4 have been conserved in these spiders. The amino
acid sequences of the toxins Magi 1, 2, 5, and 6 from the
venom of M. gigas are unique with no strong similarities to
previously reported spider toxins.
Concerning the structural organization of the Magi 4 pre-
cursor, both sequences of full-length Magi 4 and of the pre-
cursor indicate that Magi 4 is matured through the post-trans-
lational cleavage at the N-terminus by PCs. Two processing
mechanisms can be presumed. First, the twin arginine located
immediately before the N-terminus of the Magi 4 sequence
plays a role as an endoproteolytic site. Dibasic amino acids
including the RR motif are the most prevalent endoproteo-
lytic site in proprotein, prohormone, and proneuropeptides
[22]. However, the Magi 4 sequence contains Lys4-Arg5,
Lys11-Lys12, and Arg33-Lys34 that can also be recognized
by PCs as endoproteolytic sites, suggesting that PCs in the
M. gigas venom are capable of cleaving the precursor exclu-
sively at the di-arginine motif or that the tight folded form of
Magi 4 owing to four disul¢de bridges hinders the approach
of PCs to any dibasic motifs in Magi 4 sequence. Alterna-
tively, RVRR, instead of RR, is likely to serve as the cleavage
site, which is supported by the fact that some PCs specialize in
endoproteolysis at the RXRR motif [22]. Analysis of the
cDNA libraries of other spiders such as Atrax sp. [34] and
P. tristis [35] indicated that g-atracotoxins and PlTx toxins
are initially synthesized as prepro-forms which undergo elim-
ination of their signal peptide region followed by additional
processing at their N- and/or C-termini to produce the mature
products. g-Atracotoxin-Hi2a and PlTx-VIII toxin are
£anked at their N- and/or C-termini by endoproteolytic sites
Glu-Arg/Gly-Arg [34] and Glu-Arg/Arg-Arg [35], respectively,
whereas in Magi 4 the processing site at the N-terminus was
Arg/Arg. These ¢ndings indicate that the post-translational
processing of peptide toxin precursors is dependent on the
species from which the peptide toxins were isolated.
The biological activity observed by direct injection of Magi
1^5 toxins in lepidoptera correlates well with the competitive
binding experiments. Even though Magi 1 competitively binds
to site 3 against the scorpion toxin LqhKIT, it did not cause
paralytic e¡ects to insects. The concentration of Magi 1 in-
jected to the lepidoptera larvae could be not enough for caus-
ing paralysis to the larvae, or the binding of Magi 1 to insect
Naþ channels may be classi¢ed as ‘silent binding’ as seen in
other peptide toxins [19]. Magi 3 and 5 were shown to cause
only paralytic e¡ects but no lethal e¡ects to lepidoptera. Magi
3 and 5 also had the highest Ki in competitive binding to site 3
against the insect toxin LqhKIT. Magi 2 and 4 caused lethal
toxicity to lepidopteran larvae in good correlation to the com-
petitive binding data (Fig. 1A). In mice, only Magi 5 was
found to be lethal and compete with the sodium channel toxin
CssIV. Magi 4 and 6 produced neurotoxic e¡ects on mice;
however, they were unable to compete with any of the three
Fig. 3. Competitive experiments between radiolabeled scorpion tox-
ins and cold M. gigas peptide toxins. A: Competition for [125I]-
LqhKIT binding by increasing concentrations of native scorpion
LqhKIT and spider peptides Magi 1^5. Cockroach synaptosome
protein concentration was 5 Wg/ml. B: Competition for [125I]CssIV
binding by increasing concentrations of native scorpion CssIV and
spider Magi 5. Non-speci¢c binding was determined in the presence
of 1 WM LqhKIT or 1 WM CssIV and subtracted from the data.
Rat brain synaptosome protein concentration was 0.9 mg/ml. The
values were ¢t with the non-linear Hill equation. The calculated Ki
values are shown in Table 2.
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radiolabeled toxins in binding to site 3, site 4 and site 6 of the
sodium channel. Therefore, Magi 4 and 6 seem to target dif-
ferent binding site in the sodium channel of rat brain synap-
tosomes or to target di¡erent cellular receptors in mice.
Magi 1 and 2 share 68% amino acid sequence homology
with each other since 26 of their 38 amino acids are identical.
Despite high amino acid identity between these homologous
toxins, Magi 2 exhibited 80-fold more potent binding activity
to site 3 of the insect sodium channel than Magi 1. The most
remarkable amino acid di¡erences between these two peptides
are Phe16-Gly17 for Magi 1 and Lys16^Lys19 for Magi 2 where
Magi 2 has a cluster of cationic amino acids and a guanidi-
nium group at Arg18 (Table 1). A positive surface charge has
been implicated for recognition of sodium channel receptors
by scorpion toxins [13,15], and a guanidinium group is re-
sponsible for blocking sodium ion channels by cone snail tox-
ins [14,36]. Therefore, this amino acid segment found in Magi
2 but not in Magi 1 most probably accounts for this disparity
for receptor recognition in cockroach synaptosomes, and
these amino acids exclusively present in Magi 2 are expected
to confer such high a⁄nity with the low Ki value to site 3 of
the cockroach sodium channel. Since Magi 2 had no e¡ect in
mice, this peptide seems highly speci¢c for insects. Magi 2,
like the sea anemone toxin ATX-II [37], are the only peptides
reported having three disul¢de bridges that bind to site 3 of
the sodium channel. These ¢ndings are in contrast with the
fact that all scorpion and spider toxins that bind to site 3 of
the sodium channel contain four disul¢de bridges.
Magi 3 and the peptide toxin PlTx-II from the plectreurid
spider P. tristis share 43% identity in their amino acid sequen-
ces. PlTx-II has been reported to be a calcium ion channel
blocker in insects [38]. Moreover, Magi 3 was shown to bind
to the insect sodium channel (Fig. 3 and Table 2). In combi-
nation, these ¢ndings indicate the possibility that Magi 3 also
recognizes insect calcium channels. Some spider toxins have
shown promiscuity across ion channel families. For example,
ProTx-I, from the venom of the theraphosid T. pruriens, in-
hibits the tetrodotoxin-resistant Na channel, Nav 1.8, and also
modi¢es the currents of the Cav 3.1 (K1G, T-type) and the Kv
2.1 channels [8]. Moreover, grammotoxin-SIA inhibits not
only several types of calcium channels (N-type, P/Q-type)
but also potassium channels (drk1 Kþ) [12,39].
Magi 4 was able to compete with the insect toxin LqhKIT
at subpicomolar concentrations in binding to site 3. Similar
toxins such as versutoxin and atracotoxin also competitively
bind to insect synaptosomes against the insect toxin LqhKIT
at picomolar concentrations [6,40]. On the other hand, Magi 4
was found to fail to interact with site 3 of the sodium channel
in rat synaptosomes, given that Magi 4, unlike N-atracotoxin
[6], showed no competitive binding activity against the rat
sodium channel site 3 ligand, Lqh2. In addition, a newly iso-
lated toxin, N-atracotoxin-HV1b, shows a marked contrast
with Magi 4 because it completely lacks insecticidal activity
but displays an inhibitory e¡ect on the rat sodium channel
[41]. Therefore, Magi 4 and N-atracotoxins illustrate variabil-
ity for sodium channel recognition in rat and insect neurons.
Magi 4 is lethal to mice by intracranial injection, suggesting
that Magi 4 could interact with the mammalian sodium chan-
nel at a non-identical site to that of Lqh2.
Magi 5 showed displacement from 80^90% of the total
binding of the L-scorpion toxin CssIV that binds to site 4 of
the rat brain sodium channel. Antibodies speci¢c for the rat
brain sodium channel subtypes rI and rII have shown that the
content of sodium channels puri¢ed from rat brain is approx-
imately 18% rI and 80% rII [42]. In this context, Magi 5
displaced partially the binding of the L-scorpion toxin, sug-
gesting that Magi 5 may recognize a subpopulation of brain
sodium channels. This particularity of Magi 5 needs further
investigations to be con¢rmed. Moreover, Magi 5 competed
with the insect sodium toxin LqhKIT in binding to site 3 of
sodium channels, suggesting that both site 3 of insect sodium
channels and site 4 of the rat brain sodium channel might
embrace similar molecular surfaces. Magi 4 and 5 showed
strong competition for the binding to site 3 and site 4 of insect
and rat brain sodium channels, respectively. Some questions
could arise from their competitive binding activities. First,
why does Magi 4 bind to site 3 in insect, but fail to recognize
(even being lethal to mice) the related site 3 in rat brain
synaptosomes? And second, why can Magi 5 bind to both
site 3 in insects and site 4 in mammals? It is likely that bind-
ing sites in sodium channels are not independent structural
sites but belong to a common macrosite or ‘hot spot’ as has
been proposed [43], where small molecular weight toxins (i.e.
spider toxins) could be more easily accommodated than large
molecular weight toxins (i.e. scorpion toxins). Spider toxins,
especially those with low molecular masses, are becoming val-
uable tools for the investigation of the topology of ion chan-
nels. These low molecular weight ion channel modi¢ers could
be synthesized chemically and then mutated for studies to-
wards the molecular recognition of its receptors that could
permit the engineering of novel synthetic drugs. Molecular
recognition of toxin for its receptors could be achieved also
by ion channel mutagenesis. Studies on the molecular inter-
action between animal toxins and ion channel receptors have
been increasingly reported [9,11,12]. Magi 1, 2, 3, 4 and 5 are
short molecular toxins that can be easily synthesized chemi-
cally for further exploration of ion channels in both insects
and mammals. Magi 6 is also a short molecular toxin,
although its mode of action remains unknown.
Acknowledgements: We are grateful to Dr. Gurevitz for the gift of
scorpion toxins, to Drs. Naomasa Oshiro and Koki Terada for help
for collecting spiders, and to Dr. Hideo Naoki for helpful discussions.
This work was supported in part by a grant from the Research for the
Future Program from the Japanese Society for the Promotion of
Science (JSPS).
References
[1] Ford, J.W., Stevens, E.B., Treherne, J.M., Packer, J. and Bush-
¢eld, M. (2002) Prog. Drug Res. 58, 133^168.
[2] Escoubas, P., Diochot, S. and Corzo, G. (2000) Biochimie 82,
893^907.
[3] Rash, L.D. and Hodgson, W.C. (2002) Toxicon 40, 225^254.
[4] Sheumack, D.D., Claassens, R., Whiteley, N.M. and Howden,
M.E. (1985) FEBS Lett. 181, 154^156.
[5] Brown, M.R., Sheumack, D.D., Tyler, M.I. and Howden, M.E.
(1988) Biochem. J. 250, 401^405.
[6] Little, M.J., Wilson, H., Zappia, C., Cestele, S., Tyler, M.I.,
Martin-Eauclaire, M.F., Gordon, D. and Nicholson, G.M.
(1998) FEBS Lett. 439, 246^252.
[7] Corzo, G., Escoubas, P., Stankiewicz, M., Pelhate, M., Kristen-
sen, C.P. and Nakajima, T. (2000) Eur. J. Biochem. 267, 5783^
5795.
[8] Middleton, R.E., Warren, V.A., Kraus, R.L., Hwang, J.C., Liu,
C.J., Dai, G., Brochu, R.M., Kohler, M.G., Gao, Y.D., Garsky,
V.M., Bogusky, M.J., Mehl, J.T., Cohen, C.J. and Smith, M.M.
(2002) Biochemistry 41, 14734^14747.
FEBS 27417 3-7-03
G. Corzo et al./FEBS Letters 547 (2003) 43^50 49
[9] Swartz, K.J. and MacKinnon, R. (1995) Neuron 15, 941^949.
[10] Newcomb, R., Szoke, B., Palma, A., Wang, G., Chen, X., Hop-
kins, W., Cong, R., Miller, J., Urge, L., Tarczy-Hornoch, K.,
Loo, J.A., Dooley, D.J., Nadasdi, L., Tsien, R.W., Lemos, J.
and Miljanich, G. (1998) Biochemistry 37, 15353^15362.
[11] Bourinet, E., Stotz, S.C., Spaetgens, R.L., Dayanithi, G., Lemos,
J., Nargeot, J. and Zamponi, G.W. (2001) Biophys. J. 81, 79^
88.
[12] Li-Smerin, Y. and Swartz, K.J. (1998) Proc. Natl. Acad. Sci.
USA 95, 8585^8589.
[13] Froy, O., Zilberberg, N., Gordon, D., Turkov, M., Gilles, N.,
Stankiewicz, M., Pelhate, M., Loret, E., Oren, D.A., Shaanan, B.
and Gurevitz, M. (1999) J. Biol. Chem. 274, 5769^5776.
[14] Sato, K., Ishida, Y., Wakamatsu, K., Kato, R., Honda, H., Ohi-
zumi, Y., Nakamura, H., Ohya, M., Lancelin, J.M. and Kohda,
D. (1991) J. Biol. Chem. 266, 16989^16991.
[15] Zilberberg, N., Froy, O., Loret, E., Cestele, S., Arad, D., Gor-
don, D. and Gurevitz, M. (1997) J. Biol. Chem. 272, 14810^
14816.
[16] Corzo, G., Villegas, E., Hon-Seok, L. and Nakajima, T. (2001)
Protein Pept. Lett. 8, 375^383.
[17] Corzo, G., Villegas, E. and Nakajima, T. (2001) Protein Pept.
Lett. 8, 385^393.
[18] Krimm, I., Gilles, N., Sautiere, P., Stankiewicz, M., Pelhate, M.,
Gordon, D. and Lancelin, J.M. (1999) J. Mol. Biol. 285, 1749^
1763.
[19] Fainzilber, M., Kofman, O., Zlotkin, E. and Gordon, D. (1994)
J. Biol. Chem. 269, 2574^2580.
[20] Cheng, Y.C. and Pruso¡, W.H. (1973) Biochem. Pharmacol. 22,
3099^3108.
[21] Kozak, M. (1986) Nucleic Acids Res. 15, 8125^8148.
[22] Seidah, N.G. and Chretien, M. (1999) Brain Res. 848, 45^62.
[23] Branton, W.D., Rudnick, M.S., Zhou, Y., Eccleston, E.D.,
Fields, G.B. and Bowers, L.D. (1993) Nature 365, 496^497.
[24] Quistad, G.B. and Skinner, W.S. (1994) J. Biol. Chem. 269,
11098^11101.
[25] Gordon, D. (1997) Invertebr. Neurosci. 3, 103^116.
[26] Borchani, L., Mansuelle, P., Stankiewicz, M., Grolleau, F., Ces-
tele, S., Karoui, H., Lapied, B., Rochat, H., Pelhate, M. and el
Ayeb, M. (1996) Eur. J. Biochem. 241, 525^532.
[27] Amitai, Y. (1998) Public Health Rev. 26, 257^263.
[28] Eitan, M., Fowler, E., Herrmann, R., Duval, A., Pelhate, M. and
Zlotkin, E. (1990) Biochemistry 29, 5941^5947.
[29] Oren, D.A., Froy, O., Amit, E., Kleinberger-Doron, N., Gure-
vitz, M. and Shaanan, B. (1998) Structure 6, 1095^1103.
[30] Gilles, N., Chen, H., Wilson, H., Le Gall, F., Montoya, G.,
Molgo, J., Schonherr, R., Nicholson, G., Heinemann, S.H. and
Gordon, D. (2000) Eur. J. Neurosci. 12, 2823^2832.
[31] Martin, M.F., Garcia y Perez, L.G., el Ayeb, M., Kopeyan, C.,
Bechis, G., Jover, E. and Rochat, H. (1987) J. Biol. Chem. 262,
4452^4459.
[32] Thomsen, W., Martin-Eauclaire, M.F., Rochat, H. and Catterall,
W.A. (1995) J. Neurochem. 65, 1358^1364.
[33] Sautiere, P., Cestele, S., Kopeyan, C., Martinage, A., Drobecq,
H., Doljansky, Y. and Gordon, D. (1998) Toxicon 36, 1141^
1154.
[34] Wang, X.H., Connor, M., Wilson, D., Wilson, H.I., Nicholson,
G.M., Smith, R., Shaw, D., Mackay, J.P., Alewood, P.F., Chris-
tie, M.J. and King, G.F. (2001) J. Biol. Chem. 276, 40306^40312.
[35] Leisy, D.J., Mattson, J.D., Quistad, G.B., Kramer, S.J., Van
Beek, N., Tsai, L.W., Enderlin, F.E., Woodworth, A.R. and
Digan, M.E. (1996) Insect Biochem. Mol. Biol. 26, 411^417.
[36] Becker, S., Prusak-Sochaczewski, E., Zamponi, G., Beck-Sick-
inger, A.G., Gordon, R.D. and French, R.J. (1992) Biochemistry
31, 8229^8238.
[37] Wunderer, G., Fritz, H., Wachter, E. and Machleidt, W. (1976)
Eur. J. Biochem. 68, 193^198.
[38] Branton, W.D., Kolton, L., Jan, Y.N. and Jan, L.Y. (1987)
J. Neurosci. 7, 4195^4200.
[39] Lampe, R.A., Defeo, P.A., Davison, M.D., Young, J., Herman,
J.L., Spreen, R.C., Horn, M.B., Mangano, T.J. and Keith, R.A.
(1993) Mol. Pharmacol. 44, 451^460.
[40] Gilles, N., Harrison, G., Karbat, I., Gurevitz, M., Nicholson,
G.M. and Gordon, D. (2002) Eur. J. Biochem. 269, 1500^1510.
[41] Szeto, T.H., Birinyi-Strachan, L.C., Smith, R., Connor, M.,
Christie, M.J., King, G.F. and Nicholson, G.M. (2000) FEBS
Lett. 470, 293^299.
[42] Gordon, D., Merrick, D., Auld, V., Dunn, R., Goldin, A.L.,
Davidson, N. and Catterall, W.A. (1987) Proc. Natl. Acad. Sci.
USA 84, 8682^8686.
[43] Winter¢eld, J.R. and Swartz, K.J. (2000) J. Gen. Physiol. 116,
637^644.
FEBS 27417 3-7-03
G. Corzo et al./FEBS Letters 547 (2003) 43^5050
